Abstract #4193

Comparison of ferumoxytol and gadolinium enhancement changes in response to Avastin in high grade glioma patients

Andrea Horváth^1,2,3, Csanád Várallyay¹, Daniel Schwartz¹, Prakash Ambady¹, Péter Bogner⁴, and Edward Neuwelt¹

¹Department of Neurology, Oregon Health and Science University, Portland, OR, United States, ²Department of Neurosurgery, University of Pécs, Pécs, Hungary, ³Diagnsotic Center of Pécs, Pécs, Hungary, ⁴Department of Radiology, University of Pécs, Pécs, Hungary

Ferumoxytol is an alternative, investigational, iron-based MRI contrast agent, which might be beneficial in the accurate diagnosis of treated glioma patients. In this study we investigated how gadolinium and 24 hour ferumoxytol enhancement change as a result of Avastin treatment. The enhancement volumes and normalized signal intensities before and after Avastin treatment were calculated with histogram analysis and were compared between contrast agents. Changes in enhancement volumes and in signal intensities in response to Avastin were not different between contrast agents. Ferumoxytol shows good potential in brain tumor imaging.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.